Stay updated on Tolebrutinib in NRSPMS Clinical Trial
Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe Locations section has been updated with numerous new trial sites across the US, Argentina, Australia, Canada, India, and Europe. Several previously listed locations were removed.SummaryDifference2%

- Check15 days agoChange DetectedTwo India locations (122001 and 122002) updated from Gurgaon to Gūrgaon to reflect the city’s diacritic spelling.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.0%

- Check36 days agoChange Detected- Added note that publications are automatically filled from PubMed and may not be about the study. - The page revision tag was updated to v3.3.1.SummaryDifference0.0%

- Check43 days agoChange DetectedThe banner about government funding lapses and operating status updates was removed from the page.SummaryDifference0.1%

- Check58 days agoChange DetectedThe India location entry for 122001 and 122002 changed from Gūrgaon to Gurgaon in the locations list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.